Trial intelligence / Profile preview

VERU-944 for Hot Flashes in Prostate Cancer

NCT03646162Phase 2Completed

Sponsor
Veru Inc.
Start
Sep 2018
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zuclomiphene in hot flashes, sponsored by Veru Inc.. Started Sep 2018; status: completed.

02

Drugs

zuclomiphene
03

Conditions

hot flashes

Beyond the preview

Go deeper on NCT03646162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03646162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call